StageBio Acquires TPL Path Labs to Expand its Footprints Globally
Shots:
- StageBio and TPL Path Labs offers an expanded array of histopathology- molecular pathology- and related solutions to biopharma- medical device and academic researchers across the US- EU- and other countries
- The acquisition expands StageBio’s pre/ clinical laboratory resources- GLP/GCLP-compliant lab facility and staff in Germany tits existing 6 GLP-compliant lab facilities and 2 GLP specimen archive sites in the US
- The acquisition enhances StageBio ability to support clinical investigators in the areas of biomarker development- TCR and immunohistochemistry
Ref: PRNewswire | Image: Harman Professional Solutions
Click here to read the full press release
This content piece was prepared by our former Senior Editor. She had expertise in life science research and was an avid reader. For any query reach out to us at connect@pharmashots.com